News
The space environment is not kind to human bodies. The final frontier may therefore be the perfect place to study cancer — ...
FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With ...
RAHWAY, N.J., June 13, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® ...
Sentinel lymph node biopsy versus pelvic lymphadenectomy in cervical cancer: The PHENIX trial. FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) ...
Alvotech (ALVO) and Dr. Reddy’s Laboratories (RDY) have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda ...
Pts were randomized in a 2:1 ratio to receive either benmelstobart plus anlotinib (benmel+ anlo) or pembrolizumab plus placebo (pem+placebo). Anlotinib or placebo was administered orally at a dose of ...
Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...
CHICAGO — Pittsburgh Pirates catcher Endy Rodríguez is going to get a platelet-rich plasma injection for his ailing right elbow. Rodríguez got a second opinion from Dodgers team physician Dr ...
Yankees' Luke Weaver Gets PRP Injection for Hamstring Injury, Could Miss 4-6 Weeks - Bleacher Report
New York Yankees closer Luke Weaver received a platelet-rich plasma injection designed to speed healing in his injured left hamstring, according to the Associated Press (h/t ESPN).
Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1].
Women using weight-loss injections are being urged to use effective contraception, following the Medicines and Healthcare products Regulatory Agency (MHRA)'s first public alert on the use of ...
Emgality’s most common side effect is a reaction at the injection site. This can cause itching, pain, skin discoloration, or swelling. Other possible side effects include high blood pressure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results